Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.

UTI Mutual Fund

UTI Innovation Fund - Regular Plan - Payout of IDCW Option

★★★★★ TopFund est.

TopFund Score (fallback rating)

  • Calculated by: TopFund — used only when no third-party rating exists for this fund
  • Formula: 3-year trailing return percentile within category, adjusted ±1 star for expense ratio
  • Refresh frequency: Whenever TopFund re-syncs this fund's data
  • Limitations: A simplified 2-factor estimate, not equivalent to a rating agency's full analysis

Full rating methodology →

TopFund Score: 38/100 · Weak

How this score is calculated

  • Star rating (35%)1/5
  • 3Y CAGR (30%)—
  • Expense ratio (20%)1.22%
  • AUM (15%)₹790 Cr

Not investment advice — an analytical read of public fund data. Methodology →

UTI Mutual Fund · Equity · Thematic

₹12.2

+0.49 (+4.17%)

AUM: ₹789 Cr

NAV updated 20 days ago

Plan

Regular

Option

Idcw

Risk

Very High

Expense Ratio

1.22%

Exit Load

Exit load of 1%, if redeemed within 12 months.

Fund Manager

Deepesh Agarwal

Inception

Oct 2023

Benchmark

NIFTY 500 Total Return Index

Sharpe Ratio

-0.17

Std Dev (1Y)

18.51%

Historical Returns (CAGR)

Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.

1m

+1.71%

3m

+10.69%

6m

+26.03%

1y

+0.54%

3y

—

5y

—

10y

—

since inception

+5.56%

TopFund's Take on UTI Innovation Fund - Regular Plan - Payout of IDCW Option

UTI Innovation Fund - Regular Plan - Payout of IDCW Option lags behind most of its peers in the Thematic category, currently carrying a 1-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 38/100.

Cost: At 1.22%, the expense ratio runs 23% above the Thematic category average of 0.99%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.

Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -0.17 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 18.51% is fairly typical for Thematic funds.

Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.

This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.

Sector Allocation

Asset Allocation

Equity 97.44%
Net Current Assets 2.56%
CBLO 0.02%

Frequently Asked Questions about UTI Innovation Fund - Regular Plan - Payout of IDCW Option

* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

No comments yet — start the discussion.